rs1472899

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000899.5(KITLG):​c.16-11843G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.655 in 151,930 control chromosomes in the GnomAD database, including 36,439 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 36439 hom., cov: 31)

Consequence

KITLG
NM_000899.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.190

Publications

11 publications found
Variant links:
Genes affected
KITLG (HGNC:6343): (KIT ligand) This gene encodes the ligand of the tyrosine-kinase receptor encoded by the KIT locus. This ligand is a pleiotropic factor that acts in utero in germ cell and neural cell development, and hematopoiesis, all believed to reflect a role in cell migration. In adults, it functions pleiotropically, while mostly noted for its continued requirement in hematopoiesis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KITLG Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 69
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hyperpigmentation with or without hypopigmentation, familial progressive
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial progressive hyper- and hypopigmentation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial progressive hyperpigmentation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Waardenburg syndrome type 2
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Waardenburg syndrome, IIa 2F
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.793 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000899.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KITLG
NM_000899.5
MANE Select
c.16-11843G>A
intron
N/ANP_000890.1P21583-1
KITLG
NM_003994.6
c.16-11843G>A
intron
N/ANP_003985.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KITLG
ENST00000644744.1
MANE Select
c.16-11843G>A
intron
N/AENSP00000495951.1P21583-1
KITLG
ENST00000347404.10
TSL:1
c.16-11843G>A
intron
N/AENSP00000054216.5P21583-2
KITLG
ENST00000874530.1
c.16-11843G>A
intron
N/AENSP00000544589.1

Frequencies

GnomAD3 genomes
AF:
0.656
AC:
99536
AN:
151812
Hom.:
36435
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.295
Gnomad AMI
AF:
0.752
Gnomad AMR
AF:
0.780
Gnomad ASJ
AF:
0.856
Gnomad EAS
AF:
0.722
Gnomad SAS
AF:
0.795
Gnomad FIN
AF:
0.783
Gnomad MID
AF:
0.842
Gnomad NFE
AF:
0.798
Gnomad OTH
AF:
0.696
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.655
AC:
99559
AN:
151930
Hom.:
36439
Cov.:
31
AF XY:
0.660
AC XY:
49072
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.294
AC:
12173
AN:
41358
American (AMR)
AF:
0.780
AC:
11900
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.856
AC:
2968
AN:
3468
East Asian (EAS)
AF:
0.722
AC:
3723
AN:
5158
South Asian (SAS)
AF:
0.797
AC:
3844
AN:
4822
European-Finnish (FIN)
AF:
0.783
AC:
8277
AN:
10572
Middle Eastern (MID)
AF:
0.847
AC:
249
AN:
294
European-Non Finnish (NFE)
AF:
0.798
AC:
54268
AN:
67974
Other (OTH)
AF:
0.697
AC:
1471
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1376
2752
4129
5505
6881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
770
1540
2310
3080
3850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.757
Hom.:
17020
Bravo
AF:
0.636
Asia WGS
AF:
0.721
AC:
2507
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.5
DANN
Benign
0.61
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1472899; hg19: chr12-88951485; API